Sramana Mitra: If the interoperability is within the hospital data and diverse proprietary systems, it is easier. When it comes to outside the bounds of that particular hospital system, what kind of issues do you face? We are part of the Stanford hospital system. For certain procedures, our family also goes to UCSF. UCSF and
Interoperability is a hairy issue within healthcare. Drew addresses it eloquently. Sramana Mitra: Let’s start by introducing our audience to yourself as well as Lyniate.
Sramana Mitra: What are you learning? What are the key areas of leakage? Brandon Newman: We have a couple of observations. The obvious learning that we expected is there. These include an opportunity to switch utilization, go to a lower-cost medication, or help manage members.
Brandon Newman: Drugs are becoming a highly prevalent part of the overall delivery of healthcare. It has become the focus. For example, these health plans that help manage $500 million are going to enable dozens of new specialty biologic medications come to market that is not going to cost your stereotypical couple of hundred dollars.
Brandon talks about unlocking savings related to expensive versus affordable drugs. Sramana Mitra: Let’s start by introducing our audience to yourself and Xevant.
Sramana Mitra: Why is your technology just being applied to the medical aesthetic market? It sounds like the value proposition can be applied to any kind of medical instrumentation. Is that not true? Brian Phillips: That is true. We happen to operate our business within the aesthetic arena. It is a tight arena. We buy
Sramana Mitra: It sounds like the primary value proposition for the manufacturers in the use case that you provided is maintenance. Is that correct? Brian Phillips: That is one use case. I would say that is a good use case. Maintenance is understanding whether the machine is operating well and also having the ability to
Brian talks about IT in the medical aesthetics world. Sramana Mitra: Let’s introduce MedShift and yourself to our audience. Brian Phillips: Thanks for having me. I’m the CEO of MedShift. We are a medical technology company based in Charlotte, North Carolina.